Innovative Treatment in Intraocular Pressure Lowering
December 23, 2020
DURYSTA™ (bimatoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT) (1). The intracameral implant is making the case for sustained drug delivery.
1 min read